Tom Wellner is a highly experienced corporate executive who recently retired as President and Chief Executive Officer of Revera Inc., a leading global owner, operator and developer in the senior living/healthcare sector. With over three decades of substantial global experience in biotechnology, pharmaceuticals, and healthcare services, Mr. Wellner has led several organizations, including Lilly Germany GmbH, LifeLabs/CML Healthcare, Ltd., and Therapure Biopharma.
He has been a guest lecturer on international business and healthcare at Harvard, Rotman and INSEAD Schools of Business, and has been engaged in significant advisory work within public equity and venture capital communities. He currently serves on the board of Ontario Teachers’ Pension Plan (OTPP), Andlauer Health Group and has previously served on the boards of FreshBooks, Novadaq Technologies, Cipher Pharmaceuticals, various Revera entities including Sunrise Senior Living and has been an advisor to Lumira Capital.
He holds an Honours Bachelor of Science degree in Life Sciences from Queen’s University and has received the ICD.D designation from the Institute of Corporate Directors.